08 July 2020

GSK Stockmann contributed to the publication of the Chinese Outbound Investment Guide 2020

The Chinese Outbound Investment Guide 2020 has been published by the International Financial Law Review (IFLR) looking at the changes that have been occurring in Chinese outbound investment patterns and how target markets are adapting.

The guide covers numerous jurisdictions providing a general outlook.

GSK Stockmann contributed to the guide: Dr. Marcus Peter (Partner at GSK Stockmann in Luxembourg) and Kate Yu Rao (Associate at GSK Stockmann in Luxembourg) composed the chapter “Luxembourg: Renminbi crossroad” outlining the benefits of Luxembourg as an investment destination and global investment springboard for Chinese investors.

The chapter is available for download as a PDF file and free to access on the IFLR Website.


Press contact
Beate Dünschede
+352 271802-29


GSK Updates
  • 17.08.2022

    GSK Update: CAA Circular 22/15: What is new for the governance of insurance and reinsurance companies

    Read more
  • 10.02.2022

    GSK Update: Update of the Luxembourg Securitisation Law: Increased Flexibility and Legal Certainty

    Read more
  • 27.01.2022

    GSK Update: CSSF Guidance on Virtual Assets: New FAQ for UCI and credit institutions

    Read more
Contact person

Dr. Marcus Peter, LL.M.


+352 271802-50


Kate Rao, LL.M.

Senior Associate

+352 271802-54


© GSK Stockmann 2022